Shelter Pharma Ltd
Shelter Pharma Ltd (SHELTER) last traded at ₹33.9, a market capitalisation of ₹57.1 crore, on a P/E of 6.33. Over the past 52 weeks the stock has ranged between ₹23 and ₹48. Shelter Pharma Ltd last reported results for the quarter ended Mar 2026, with sales of ₹39.84 crore and net profit of ₹4.53 crore. Figures are as of 25 Aug 2026 and are not real time.
Shelter Pharma Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Shelter Pharma Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹39.84 cr, up 49.8% from ₹26.6 cr a year earlier. Net profit was ₹4.53 cr, up 22.4% year on year.
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 17.02 | 19.13 | 19.31 | 20.71 | 24.06 | 26.6 | 33.29 | 39.84 |
| Expenses | 13.71 | 14.82 | 15.02 | 16.42 | 19.16 | 21.42 | 27.03 | 33.37 |
| Operating profit | 3.31 | 4.31 | 4.29 | 4.29 | 4.9 | 5.18 | 6.26 | 6.47 |
| OPM % | 19.45% | 22.53% | 22.22% | 20.71% | 20.37% | 19.47% | 18.80% | 16.24% |
| Other income | 0 | -0.45 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Interest | 0.01 | 0.01 | 0.05 | 0 | 0.07 | 0.06 | 0.06 | 0.05 |
| Depreciation | 0.08 | 0.08 | 0.12 | 0.13 | 0.1 | 0.17 | 0.19 | 0.22 |
| Profit before tax | 3.22 | 3.77 | 4.12 | 4.16 | 4.73 | 4.95 | 6.01 | 6.21 |
| Tax % | 25.47% | 25.46% | 24.76% | 25.00% | 25.16% | 25.05% | 25.29% | 27.05% |
| Net profit | 2.4 | 2.81 | 3.1 | 3.12 | 3.54 | 3.7 | 4.5 | 4.53 |
| EPS (₹) | 49.59 | 3.63 | 2.68 | 2.70 | 3.06 | 3.20 | 3.89 | 2.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Shelter Pharma Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 22.48 | 30.06 | 36.15 | 39.93 | 50.64 | 73.13 |
| Operating profit | 0.19 | 3.05 | 8.15 | 8.79 | 10.07 | 12.72 |
| OPM % | 0.85% | 10.15% | 22.54% | 22.01% | 19.89% | 17.39% |
| Net profit | 0.04 | 2.06 | 5.21 | 6.2 | 7.24 | 9.03 |
| EPS (₹) | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 | 5.44 |
TTM is the trailing twelve months to the most recent quarter.
Shelter Pharma Ltd growth and returns
- 10 Years
- 10%
- 5 Years
- 27%
- 3 Years
- 26%
- TTM
- 44%
- 10 Years
- 68%
- 5 Years
- 196%
- 3 Years
- 15%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -6%
- 1 Year
- -31%
- 10 Years
- %
- 5 Years
- 21%
- 3 Years
- 18%
- Last Year
- 15%
Shelter Pharma Ltd shareholding pattern
Promoters held 44.38% at May 2026, down from 52.32% at Mar 2025.
| % held | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Nov 2025 | Mar 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 56.89% | 56.89% | 54.97% | 52.32% | 52.32% | 47.19% | 44.99% | 44.38% |
| Public | 43.11% | 43.12% | 45.03% | 47.68% | 47.68% | 52.82% | 55.00% | 55.61% |
| No. of shareholders | 836 | 868 | 1,119 | 1,153 | 1,094 | 1,093 | 1,060 | 1,089 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Shelter Pharma Ltd corporate filings
- Intimation Under Regulation 30 of SEBI LODR (Regulation) - 2015 Completion and Commencement of Dispatch of Export OrderCompany Updatehigh impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order of…
Read the full analysis - Intimation Under Regulation 30 of SEBI LODR (Regulation) - 2015 Completion and Commencement of Dispatch of Export OrderCompany Updatemedium impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order for…
Read the full analysis - Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- New Product LaunchCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Ltd has issued an intimation regarding the launch of a new product in…
Read the full analysis - Intimation under Regulation 30 of SEBI LODR (Regulation)- 2015 Completion and Commencement of Dispatch of Export OrderCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed the manufacturing and dispatch of an…
Read the full analysis - Intimation Under Regulation 30 of SEBI (Regulation) 2015- Completion and Commencement of Dispatch of Export Order.Company Updatemedium impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order for 'All…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Shelter Pharma Ltd
Cruxal reads every Shelter Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.